亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Analysis of upfront resection or stereotactic radiosurgery for local control of solid and cystic cerebellar hemangioblastomas

医学 放射外科 血管母细胞瘤 单变量分析 外科 肿瘤进展 回顾性队列研究 多元分析 放射科 癌症 放射治疗 内科学
作者
Luis R. Carrete,Ramin A. Morshed,Jacob S. Young,Lauro N. Avalos,Penny K. Sneed,Manish K. Aghi,Michael W. McDermott,Philip V. Theodosopoulos
出处
期刊:Journal of Neurosurgery [Journal of Neurosurgery Publishing Group]
卷期号:140 (2): 404-411 被引量:2
标识
DOI:10.3171/2023.6.jns222629
摘要

OBJECTIVE The purpose of this study was to identify rates of and risk factors for local tumor progression in patients who had undergone surgery or radiosurgery for the management of cerebellar hemangioblastoma and to describe treatments pursued following tumor progression. METHODS The authors conducted a retrospective single-center review of patients who had undergone treatment of a cerebellar hemangioblastoma with either surgery or stereotactic radiosurgery (SRS) between 1996 and 2019. Univariate and multivariate regression analyses were performed to examine factors associated with local tumor control. RESULTS One hundred nine patients met the study inclusion criteria. Overall, these patients had a total of 577 hemangioblastomas, 229 of which were located in the cerebellum. The surgical and SRS cohorts consisted of 106 and 123 cerebellar hemangioblastomas, respectively. For patients undergoing surgery, tumors were treated with subtotal resection and gross-total resection in 5.7% and 94.3% of cases, respectively. For patients receiving SRS, the mean target volume was 0.71 cm 3 and the mean margin dose was 18.0 Gy. Five-year freedom from lesion progression for the surgical and SRS groups was 99% and 82%, respectively. The surgical and SRS cohorts contained 32% versus 97% von Hippel–Lindau tumors, 78% versus 7% cystic hemangioblastomas, and 12.8- versus 0.56-cm 3 mean tumor volumes, respectively. On multivariate analysis, factors associated with local tumor progression in the SRS group included older patient age (HR 1.06, 95% CI 1.03–1.09, p < 0.001) and a cystic component (HR 9.0, 95% CI 2.03–32.0, p = 0.001). Repeat SRS as salvage therapy was used more often for smaller tumor recurrences, and no tumor recurrences of < 1.0 cm 3 required additional salvage surgery following repeat SRS. CONCLUSIONS Both surgery and SRS achieve high rates of local control of hemangioblastomas. Age and cystic features are associated with local progression after SRS treatment for cerebellar hemangioblastomas. In cases of local tumor recurrence, salvage surgery and repeat SRS are valid forms of treatment to achieve local tumor control, although resection may be preferable for larger recurrences.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
五五完成签到 ,获得积分10
4秒前
领导范儿应助小小K采纳,获得10
4秒前
深情安青应助肉肉采纳,获得10
4秒前
12秒前
12秒前
科研通AI6.1应助hu970采纳,获得30
12秒前
15秒前
小小K发布了新的文献求助10
16秒前
任性学姐发布了新的文献求助10
18秒前
肉肉发布了新的文献求助10
19秒前
22秒前
23秒前
25秒前
hu970发布了新的文献求助30
27秒前
火鸡味锅巴完成签到 ,获得积分10
32秒前
abc应助liyuling采纳,获得10
36秒前
howgoods完成签到 ,获得积分10
37秒前
爱自己的宇宙完成签到,获得积分10
39秒前
40秒前
45秒前
完美世界应助科研通管家采纳,获得10
46秒前
温暖听兰发布了新的文献求助10
49秒前
MGraceLi_sci完成签到,获得积分10
1分钟前
修辛完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
心随以动完成签到 ,获得积分10
1分钟前
科研通AI6.1应助任性学姐采纳,获得10
1分钟前
桐桐应助任性学姐采纳,获得10
1分钟前
脑洞疼应助任性学姐采纳,获得10
1分钟前
852应助任性学姐采纳,获得10
1分钟前
桐桐应助任性学姐采纳,获得10
1分钟前
科研通AI6.1应助任性学姐采纳,获得10
1分钟前
科研通AI6.1应助任性学姐采纳,获得10
1分钟前
科研通AI6.1应助任性学姐采纳,获得10
1分钟前
桐桐应助任性学姐采纳,获得10
1分钟前
隐形曼青应助任性学姐采纳,获得10
1分钟前
温暖听兰发布了新的文献求助30
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Human Embryology and Developmental Biology 7th Edition 2000
The Developing Human: Clinically Oriented Embryology 12th Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
„Semitische Wissenschaften“? 1110
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5739381
求助须知:如何正确求助?哪些是违规求助? 5385826
关于积分的说明 15339673
捐赠科研通 4881965
什么是DOI,文献DOI怎么找? 2624032
邀请新用户注册赠送积分活动 1572725
关于科研通互助平台的介绍 1529527